vs

Side-by-side financial comparison of MongoDB, Inc. (MDB) and SelectQuote, Inc. (SLQT). Click either name above to swap in a different company.

MongoDB, Inc. is the larger business by last-quarter revenue ($628.3M vs $537.1M, roughly 1.2× SelectQuote, Inc.). SelectQuote, Inc. runs the higher net margin — 12.9% vs -0.3%, a 13.2% gap on every dollar of revenue. On growth, MongoDB, Inc. posted the faster year-over-year revenue change (18.7% vs 11.6%). MongoDB, Inc. produced more free cash flow last quarter ($141.8M vs $-1.0M). Over the past eight quarters, SelectQuote, Inc.'s revenue compounded faster (19.5% CAGR vs 17.1%).

MongoDB, Inc. is an American software company that develops and provides commercial support for the source-available database engine MongoDB, a database for unstructured data. Over the years, the company has expanded the product from its NoSQL roots to have broader appeal to enterprise customers, such as adding ACID and transactions.

SelectQuote is a direct-to-consumer distribution platform for selling insurance policies and healthcare services. Their insurance business earns commissions by connecting consumers with insurance carriers that provide senior health, life, automobile, and home insurance. The healthcare services business mainly consists of SelectRx, an accredited pharmacy. The company went public on May 21, 2020.

MDB vs SLQT — Head-to-Head

Bigger by revenue
MDB
MDB
1.2× larger
MDB
$628.3M
$537.1M
SLQT
Growing faster (revenue YoY)
MDB
MDB
+7.0% gap
MDB
18.7%
11.6%
SLQT
Higher net margin
SLQT
SLQT
13.2% more per $
SLQT
12.9%
-0.3%
MDB
More free cash flow
MDB
MDB
$142.9M more FCF
MDB
$141.8M
$-1.0M
SLQT
Faster 2-yr revenue CAGR
SLQT
SLQT
Annualised
SLQT
19.5%
17.1%
MDB

Income Statement — Q3 FY2026 vs Q2 FY2026

Metric
MDB
MDB
SLQT
SLQT
Revenue
$628.3M
$537.1M
Net Profit
$-2.0M
$69.3M
Gross Margin
71.5%
61.8%
Operating Margin
-2.9%
14.0%
Net Margin
-0.3%
12.9%
Revenue YoY
18.7%
11.6%
Net Profit YoY
79.5%
30.2%
EPS (diluted)
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDB
MDB
SLQT
SLQT
Q4 25
$628.3M
$537.1M
Q3 25
$591.4M
$328.8M
Q2 25
$549.0M
$345.1M
Q1 25
$548.4M
$408.2M
Q4 24
$529.4M
$481.1M
Q3 24
$478.1M
$292.3M
Q2 24
$450.6M
$307.2M
Q1 24
$458.0M
$376.4M
Net Profit
MDB
MDB
SLQT
SLQT
Q4 25
$-2.0M
$69.3M
Q3 25
$-47.0M
$-30.5M
Q2 25
$-37.6M
$12.9M
Q1 25
$15.8M
$26.0M
Q4 24
$-9.8M
$53.2M
Q3 24
$-54.5M
$-44.5M
Q2 24
$-80.6M
$-31.0M
Q1 24
$-55.5M
$8.6M
Gross Margin
MDB
MDB
SLQT
SLQT
Q4 25
71.5%
61.8%
Q3 25
71.0%
41.4%
Q2 25
71.2%
47.2%
Q1 25
72.8%
60.2%
Q4 24
74.4%
67.5%
Q3 24
73.2%
55.7%
Q2 24
72.8%
60.7%
Q1 24
75.0%
71.8%
Operating Margin
MDB
MDB
SLQT
SLQT
Q4 25
-2.9%
14.0%
Q3 25
-11.0%
-12.4%
Q2 25
-9.8%
-3.6%
Q1 25
-3.4%
5.4%
Q4 24
-5.3%
14.7%
Q3 24
-14.9%
-4.1%
Q2 24
-21.8%
-0.5%
Q1 24
-15.5%
8.8%
Net Margin
MDB
MDB
SLQT
SLQT
Q4 25
-0.3%
12.9%
Q3 25
-8.0%
-9.3%
Q2 25
-6.9%
3.7%
Q1 25
2.9%
6.4%
Q4 24
-1.8%
11.1%
Q3 24
-11.4%
-15.2%
Q2 24
-17.9%
-10.1%
Q1 24
-12.1%
2.3%
EPS (diluted)
MDB
MDB
SLQT
SLQT
Q4 25
$0.26
Q3 25
$-0.26
Q2 25
$-0.06
Q1 25
$0.03
Q4 24
$0.30
Q3 24
$-0.26
Q2 24
$-0.17
Q1 24
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDB
MDB
SLQT
SLQT
Cash + ST InvestmentsLiquidity on hand
$834.1M
$18.3M
Total DebtLower is stronger
$405.8M
Stockholders' EquityBook value
$2.9B
$359.7M
Total Assets
$3.6B
$1.4B
Debt / EquityLower = less leverage
1.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDB
MDB
SLQT
SLQT
Q4 25
$834.1M
$18.3M
Q3 25
$647.1M
$10.7M
Q2 25
$657.8M
$32.4M
Q1 25
$490.1M
$80.1M
Q4 24
$673.1M
$7.3M
Q3 24
$1.3B
$10.4M
Q2 24
$815.7M
$42.7M
Q1 24
$803.0M
$37.8M
Total Debt
MDB
MDB
SLQT
SLQT
Q4 25
$405.8M
Q3 25
$393.1M
Q2 25
$385.1M
Q1 25
$391.5M
Q4 24
$711.9M
Q3 24
$680.4M
Q2 24
$683.3M
Q1 24
$686.0M
Stockholders' Equity
MDB
MDB
SLQT
SLQT
Q4 25
$2.9B
$359.7M
Q3 25
$2.9B
$305.1M
Q2 25
$3.0B
$351.1M
Q1 25
$2.8B
$350.2M
Q4 24
$1.5B
$326.0M
Q3 24
$1.4B
$269.4M
Q2 24
$1.3B
$316.8M
Q1 24
$1.1B
$346.8M
Total Assets
MDB
MDB
SLQT
SLQT
Q4 25
$3.6B
$1.4B
Q3 25
$3.5B
$1.2B
Q2 25
$3.6B
$1.2B
Q1 25
$3.4B
$1.3B
Q4 24
$3.2B
$1.3B
Q3 24
$3.1B
$1.1B
Q2 24
$3.0B
$1.2B
Q1 24
$2.9B
$1.2B
Debt / Equity
MDB
MDB
SLQT
SLQT
Q4 25
1.13×
Q3 25
1.29×
Q2 25
1.10×
Q1 25
1.12×
Q4 24
2.18×
Q3 24
2.53×
Q2 24
2.16×
Q1 24
1.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDB
MDB
SLQT
SLQT
Operating Cash FlowLast quarter
$143.5M
$52.0K
Free Cash FlowOCF − Capex
$141.8M
$-1.0M
FCF MarginFCF / Revenue
22.6%
-0.2%
Capex IntensityCapex / Revenue
0.3%
0.2%
Cash ConversionOCF / Net Profit
0.00×
TTM Free Cash FlowTrailing 4 quarters
$346.3M
$8.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDB
MDB
SLQT
SLQT
Q4 25
$143.5M
$52.0K
Q3 25
$72.1M
$-21.6M
Q2 25
$109.9M
$-37.5M
Q1 25
$50.5M
$71.1M
Q4 24
$37.4M
$-28.7M
Q3 24
$-1.4M
$-16.6M
Q2 24
$63.6M
$20.0M
Q1 24
$54.6M
$44.5M
Free Cash Flow
MDB
MDB
SLQT
SLQT
Q4 25
$141.8M
$-1.0M
Q3 25
$71.6M
$-22.7M
Q2 25
$108.3M
$-38.0M
Q1 25
$24.6M
$70.2M
Q4 24
$35.5M
$-29.0M
Q3 24
$-2.4M
$-17.1M
Q2 24
$63.1M
$19.7M
Q1 24
$51.9M
$43.4M
FCF Margin
MDB
MDB
SLQT
SLQT
Q4 25
22.6%
-0.2%
Q3 25
12.1%
-6.9%
Q2 25
19.7%
-11.0%
Q1 25
4.5%
17.2%
Q4 24
6.7%
-6.0%
Q3 24
-0.5%
-5.8%
Q2 24
14.0%
6.4%
Q1 24
11.3%
11.5%
Capex Intensity
MDB
MDB
SLQT
SLQT
Q4 25
0.3%
0.2%
Q3 25
0.1%
0.3%
Q2 25
0.3%
0.1%
Q1 25
4.7%
0.2%
Q4 24
0.4%
0.1%
Q3 24
0.2%
0.2%
Q2 24
0.1%
0.1%
Q1 24
0.6%
0.3%
Cash Conversion
MDB
MDB
SLQT
SLQT
Q4 25
0.00×
Q3 25
Q2 25
-2.91×
Q1 25
3.19×
2.73×
Q4 24
-0.54×
Q3 24
Q2 24
Q1 24
5.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDB
MDB

Mongo DB Atlas Related$470.4M75%
Other Subscription$138.7M22%
Services$19.2M3%

SLQT
SLQT

Healthcare Services Segment$230.7M43%
Pharmacy$227.2M42%
Other$30.4M6%
Final Expense$20.4M4%
Term$18.5M3%
Other Senior$6.3M1%
All Other Revenue$3.9M1%

Related Comparisons